BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2000
View Archived Issues
Genentech moves products forward in Q2 2000
Read More
BCY Ventures selects lead compound for CF therapy
Read More
Inhaled furosemide reduces experimental dyspnea in humans
Read More
Brasofensine coadministered with levodopa/carbidopa in PD patients
Read More
Phase I trial of edaravone further defines pharmacokinetic profile
Read More
Extended intervention time interval demonstrated for AM-36
Read More
Renally impaired subjects tolerate AMP-579 well, without dose adjustment
Read More
Linear pharmacokinetics, good tolerance reported for SKP-450 in healthy volunteers
Read More
Atosiban effectively and safely delays preterm birth; major European launch reported
Read More
Fujisawa seeks Canadian approval of tacrolimus ointment; FDA reschedules advisory committee meeting
Read More
Preclinical results for NCX-2216 support its development for Alzheimer's disease
Read More
SmithKline Beecham submits sNDA for Paxil for use in PTSD
Read More
Antiinflammatory drug candidate acquired by Discovery Therapeutics advances to phase II
Read More
Vion begins phase I trial of intravenous TAPET at Royal Marsden Hospital
Read More
Immunoconjugates claimed by Progenics for treatment, diagnosis of AIDS
Read More
Recently issued patent covers new Haemophilus vaccines
Read More
New allogeneic cancer vaccines in development at Onyvax
Read More
Peptides synthesized at Eisai modulate active oxygen production in neutrophils
Read More
Fujisawa presents new series of hypoglycemic agents
Read More
Compounds for beta3-adrenoceptor-related disorders designed at Asahi
Read More
Chemokine CCR3 receptor modulators claimed by DuPont in recent patent literature
Read More
Chiron halts clinical development of rhIGF-I in osteoarthritis
Read More
DPC-681 and DPC-684, new HIV protease inhibitors selected as clinical candidates
Read More
Arrow Therapeutics and Triangle Pharmaceuticals establish collaboration for antiviral agents
Read More
Neurocrine and Taisho complete final agreement; preliminary phase I data for NBI-6024 promising
Read More
Photofrin distribution agreement established
Read More
Pharmacyclics updates Xcytrin clinical trial progress
Read More
Licensing opportunity from NIH: polypeptides binding with HIV-1 gp120
Read More